Basal Cell Carcinoma, Multiple disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Aliases & Classifications for Basal Cell Carcinoma, Multiple

MalaCards integrated aliases for Basal Cell Carcinoma, Multiple:

Name: Basal Cell Carcinoma, Multiple ¹⁹ ⁵³ ⁵ ⁷¹

Multiple Basal Cell Carcinoma ¹⁹

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases Genetic diseases
Anatomical: Skin diseases Respiratory diseases Mental diseases

See all MalaCards categories (disease lists)

External Ids:

UMLS ⁷¹ C1854245

Sources

Summaries for Basal Cell Carcinoma, Multiple

MalaCards based summary: Basal Cell Carcinoma, Multiple, also known as multiple basal cell carcinoma, is related to basal cell nevus syndrome and basal cell carcinoma 1. An important gene associated with Basal Cell Carcinoma, Multiple is CCNH (Cyclin H). The drugs Verteporfin and Photosensitizing Agents have been mentioned in the context of this disorder. Affiliated tissues include skin and lung.

Sources

Related Diseases for Basal Cell Carcinoma, Multiple

Diseases in the Small Cell Carcinoma family:

Basal Cell Carcinoma 1	Basal Cell Carcinoma 2
Basal Cell Carcinoma 3	Basal Cell Carcinoma 4
Basal Cell Carcinoma 5	Basal Cell Carcinoma 6
Basal Cell Carcinoma 7	Basal Cell Carcinoma
Large Cell Carcinoma	Basal Cell Carcinoma, Multiple

Diseases related to Basal Cell Carcinoma, Multiple via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 26)

#	Related Disease	Score	Top Affiliating Genes
1	basal cell nevus syndrome	31.3	PTCH1 LOC100507346
2	basal cell carcinoma 1	30.9	RASA1 PTCH1 LOC100507346 CCNH
3	basal cell carcinoma	29.4	RASA1 PTCH1 CYP1A1
4	angioosteohypertrophic syndrome	10.0	RASA1 CCNH
5	telangiectasia, hereditary hemorrhagic, type 1	10.0	RASA1 CCNH
6	capillary malformation-arteriovenous malformation 1	10.0	RASA1 CCNH
7	muir-torre syndrome	10.0
8	nevus, epidermal	10.0
9	basal cell carcinoma 2	10.0
10	keratoacanthoma	10.0
11	merkel cell carcinoma	10.0
12	vulva basal cell carcinoma	10.0
13	tinea capitis	10.0
14	dermatophytosis	10.0
15	hemangioma, capillary infantile	9.9	RASA1 CCNH
16	klippel-trenaunay-weber syndrome	9.9	RASA1 CCNH
17	hereditary hemorrhagic telangiectasia	9.9	RASA1 CCNH
18	overgrowth syndrome	9.7	PTCH1 LOC100507346
19	holoprosencephaly 7	9.7	PTCH1 LOC100507346
20	precocious puberty	9.7	PTCH1 LOC100507346
21	congenital hydrocephalus	9.7	PTCH1 LOC100507346
22	polydactyly, postaxial, type a1	9.7	PTCH1 LOC100507346
23	colobomatous microphthalmia	9.7	PTCH1 LOC100507346
24	lung squamous cell carcinoma	9.6	RASA1 CYP1A1
25	inherited cancer-predisposing syndrome	9.6	PTCH1 LOC100507346
26	bap1 tumor predisposition syndrome	9.5	PTCH1 LOC100507346

Graphical network of the top 20 diseases related to Basal Cell Carcinoma, Multiple:

Sources

Symptoms & Phenotypes for Basal Cell Carcinoma, Multiple

Sources

Drugs & Therapeutics for Basal Cell Carcinoma, Multiple

Drugs for Basal Cell Carcinoma, Multiple (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Verteporfin

Approved, Investigational

Phase 3

129497-78-5

5362420

2

Photosensitizing Agents

Phase 3

3

Dermatologic Agents

Phase 3

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	A Randomized, Placebo-Controlled, Masked, Multicenter Phase III Study Of Photodynamic Therapy With Verteporfin For Injection (VFI) For The Treatment Of Multiple Basal Cell Carcinoma	Terminated	NCT00049959	Phase 3	verteporfin PDT
2	Registration of Oral Hedgehog Inhibitors Vismodegib and Sonidegib in the Treatment of Advanced and Multiple Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study.	Recruiting	NCT05463757		Vismodegib;Sonidegib

Search NIH Clinical Center for Basal Cell Carcinoma, Multiple

Sources

Genetic Tests for Basal Cell Carcinoma, Multiple

Sources

Anatomical Context for Basal Cell Carcinoma, Multiple

Organs/tissues related to Basal Cell Carcinoma, Multiple:

MalaCards : Skin, Lung

Sources

Publications for Basal Cell Carcinoma, Multiple

Articles related to Basal Cell Carcinoma, Multiple:

(show top 50) (show all 74)

#	Title	Authors	PMID	Year
1	[Skeletal and dermatological manifestations of the nevoid Basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Results of 8 patients in 12 years]. ⁵³ ⁶²	Rupprecht M...Pogoda P	17492539	2007
2	Molecular characterization of Italian nevoid basal cell carcinoma syndrome patients. ⁵³ ⁶²	Pastorino L...Bianchi-Scarra G	15712338	2005
3	A new germline mutation of the PTCH gene in a Japanese patient with nevoid basal cell carcinoma syndrome associated with meningioma. ⁵³ ⁶²	Tate G...Mitsuya T	12604725	2003
4	Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction. ⁵³ ⁶²	Lear JT...Fryer AA	9077484	1997
5	A case of nevoid basal cell carcinoma syndrome dominated by facial basal cell carcinoma. ⁶²	Qiu F...Zuo C	35545332	2022
6	Heterogeneous Skin Phantoms for Experimental Validation of Microwave-Based Diagnostic Tools. ⁶²	Boparai J...Popovic M	35271102	2022
7	Case report: B7-H3 CAR-T therapy partially controls tumor growth in a basal cell carcinoma patient. ⁶²	Hu G...Luo M	36059640	2022
8	Perianal Basal Cell Carcinoma: 35-Year Experience. ⁶²	Liu S...Kelley SR	35714341	2021
9	Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study. ⁶²	Verkouteren BJA...Mosterd K	33462360	2021
10	5-aminolevulinic acid photodynamic therapy and excision surgery for nevoid basal cell carcinoma syndrome with multiple basal cell carcinomas and PTCH1 mutation. ⁶²	Li C...Zhang X	32835883	2020
11	Studying the multiple faces of nevoid basal-cell carcinoma syndrome: A case series. ⁶²	Saxena S...Sankhla B	33456241	2020
12	Submental and Anterior Neck Originated Full-Thickness Skin Grafts for Periocular Procedures. ⁶²	Ben Artsi E...Malhotra R	31743277	2020
13	A clinical review of reconstructive techniques for patients with multiple skin cancers on the face. ⁶²	Kim GW...Lee DM	30282429	2018
14	Multiple Basal Cell Carcinoma Arising in a Verrucous Epidermal Naevus: Clinical, Histological and Therapeutic Observations. ⁶²	Satolli F...Feliciani C	28759100	2018
15	Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution. ⁶²	Kuo KY...Sarin KY	28392289	2017
16	Confocal and dermoscopic features of basal cell carcinoma in Gorlin-Goltz syndrome: A case report. ⁶²	Casari A...Longo C	26768321	2017
17	The clinicopathological spectrum of trichoepitheliomas: a retrospective descriptive study. ⁶²	du Toit JP...Jordaan HF	26220252	2016
18	Treatment of multiple unresectable basal cell carcinomas from Gorlin-Goltz syndrome: a case report. ⁶²	Ojevwe FO...Kohlitz P	25750342	2015
19	Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation. ⁶²	Rodrigues AL...Mota-Vieira L	25117323	2014
20	Metastatic Basal cell carcinoma accompanying gorlin syndrome. ⁶²	Bilir Y...Yaman E	25506011	2014
21	Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci. ⁶²	Garavelli L...Superti-Furga A	24124115	2013
22	Familial Multiple Basal Cell Carcinoma (Gorlin's Syndrome): A Case Report of a Father and Son. ⁶²	Nikam B...Garg A	24249904	2013
23	Treatment of Gorlin syndrome (nevoid basal cell carcinoma syndrome) with methylaminolevulinate photodynamic therapy in seven patients, including two children: interest of tumescent anesthesia for pain control in children. ⁶²	Girard C...Guillot B	22500823	2013
24	Multiple metastatic basal cell carcinoma with concurrent metastatic pleomorphic sarcoma in chronic lymphedema area--case report. ⁶²	Oliveira Gda P...Mello Junior EJ	23197211	2012
25	Oral diffuse B-cell non-Hodgkin's lymphoma associated to Gorlin-Goltz syndrome: a case report with one year follow-up. ⁶²	Pereira CM...Botelho Tde L	21623100	2011
26	Cutaneous cancers in an interventional cardiologist: a cautionary tale. ⁶²	Eagan JT...Jones CT	21114530	2011
27	Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ⁶²	Venkatarajan S...Orengo I	21199636	2010
28	Risk factors for single and multiple basal cell carcinomas. ⁶²	Kiiski V...Nijsten T	20713815	2010
29	Simultaneous treatment of multiple basal cell carcinoma lesions. ⁶²	Montgomery L...Clark BG	19029050	2008
30	Multiple hypersonographic spots in basal cell carcinoma. ⁶²	Uhara H...Saida T	17903154	2007
31	Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma. ⁶²	Triesscheijn M...Baas P	16984216	2006
32	Impaired removal of 8-hydroxydeoxyguanosine induced by UVB radiation in naevoid basal cell carcinoma syndrome cells. ⁵³	Nishigori C...Miyachi Y	16280022	2005
33	Long-term toxic effects of radiations: sarcomatoid carcinoma and multiple basal cell carcinoma of the limbs in chronic radiodermatitis. ⁶²	Foti C...Angelini G	15803869	2005
34	Delineation of an interstitial 9q22 deletion in basal cell nevus syndrome. ⁵³	Boonen SE...Tumer Z	15690381	2005
35	Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infection. ⁶²	Colebunders R...Van Marck E	15544700	2004
36	Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. ⁵³	Kimonis VE...Pastakia B	15545745	2004
37	Onset of multiple basal cell carcinoma 60 years after X-ray treatment for tinea capitis. ⁶²	Schena D...Chieregato G	15096161	2004
38	Tissue and tumor mosaicism of the myotonin protein kinase gene trinucleotide repeat in a patient with multiple basal cell carcinomas associated with myotonic dystrophy. ⁶²	Banuls J...Vergara G	14726854	2004
39	Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient. ⁶²	Zimmermann A...Klein SD	12647016	2003
40	Novel mutations in the PATCHED gene in basal cell nevus syndrome. ⁵³	Lam CW...Luk NM	12175781	2002
41	Ultrapulse CO2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome. ⁵³	Nouri K...Jimenez GP	11896785	2002
42	[Experience with glyciphonic ointment therapy for primary multiple basal cell carcinoma of the skin]. ⁶²	Studentsova IA...Garaev RS	12530271	2002
43	[Gorlin-Goltz syndrome]. ⁵³	Vescovi P...Bonanini M	11744885	2001
44	Two male patients with nevoid basal cell carcinoma syndrome from Turkey. ⁶²	Tumer C...Atac A	11765170	2001
45	PTCH mutations in squamous cell carcinoma of the skin. ⁶²	Ping XL...Tsou HC	11286632	2001
46	A novel polymorphism in the PTC gene allows easy identification of allelic loss in basal cell nevus syndrome lesions. ⁵³	Zedan W...High AS	11277394	2001
47	Nonsyndromic type of hereditary multiple basal cell carcinoma. ⁶²	Happle R	11078568	2000
48	Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis. ⁶²	Beswick SJ...Smith AG	11012589	2000
49	[Clinico-epidemiologic characteristics of superficial multiple basal cell carcinoma at the Dermatovenereology Clinic in Novi Sad 1986-1996]. ⁶²	Stojanovic S...Preveden R	10352507	1999
50	Multiple basal cell carcinoma developing two years after 60Co irradiation. ⁶²	Iwamoto I...Suzuki H	9649688	1998

Sources

Genes for Basal Cell Carcinoma, Multiple

Genes related to Basal Cell Carcinoma, Multiple (4 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	CCNH	Cyclin H	Protein Coding	425	Pathogenic ⁵ Likely pathogenic ⁵
2	RASA1	RAS P21 Protein Activator 1	Protein Coding	425	Pathogenic ⁵ Likely pathogenic ⁵
3	PTCH1	Patched 1	Protein Coding	411.35	Pathogenic ⁵ Novoseek inferred ⁵³	8001963 7829076 12175781 (more) 15690381 16280022 17492539 15545745 8352281 11896785 15712338 11277394 11744885 12604725
4	LOC100507346	Uncharacterized LOC100507346	RNA Gene	400	Pathogenic ⁵
5	CYP1A1	Cytochrome P450 Family 1 Subfamily A Member 1	Protein Coding	4.6	Novoseek inferred ⁵³	9077484

Sources

Variations for Basal Cell Carcinoma, Multiple

ClinVar genetic disease variations for Basal Cell Carcinoma, Multiple:

⁵ (show all 38)

#	Gene	Name	Type	Significance	ClinVarId	dbSNP ID	Position
1	RASA1, CCNH	NM_002890.3(RASA1):c.656C>G (p.Ser219Ter)	SNV	Pathogenic	464870	rs1554044823	GRCh37: 5:86627281-86627281 GRCh38: 5:87331464-87331464
2	RASA1, CCNH	NM_002890.3(RASA1):c.2131C>T (p.Arg711Ter)	SNV	Pathogenic	213660	rs863223718	GRCh37: 5:86672329-86672329 GRCh38: 5:87376512-87376512
3	PTCH1	NM_000264.5(PTCH1):c.938C>G (p.Ser313Ter)	SNV	Pathogenic	576491	rs1564055259	GRCh37: 9:98242679-98242679 GRCh38: 9:95480397-95480397
4	PTCH1, LOC100507346	NM_000264.5(PTCH1):c.2380C>T (p.Gln794Ter)	SNV	Pathogenic	931311	rs1840094606	GRCh37: 9:98229578-98229578 GRCh38: 9:95467296-95467296
5	RASA1, CCNH	NM_002890.3(RASA1):c.2925+1G>A	SNV	Likely Pathogenic	931156	rs1762099168	GRCh37: 5:86682721-86682721 GRCh38: 5:87386904-87386904
6	PTCH1	NM_000264.5(PTCH1):c.3337C>T (p.Arg1113Cys)	SNV	Uncertain Significance	823625	rs758520331	GRCh37: 9:98215872-98215872 GRCh38: 9:95453590-95453590
7	PTCH1	NM_000264.5(PTCH1):c.4178C>T (p.Pro1393Leu)	SNV	Uncertain Significance	931606	rs1368334005	GRCh37: 9:98209360-98209360 GRCh38: 9:95447078-95447078
8	PTCH1	NM_000264.5(PTCH1):c.1067+5G>C	SNV	Uncertain Significance	237448	rs372657547	GRCh37: 9:98242246-98242246 GRCh38: 9:95479964-95479964
9	PTCH2	NM_003738.5(PTCH2):c.3347C>T (p.Pro1116Leu)	SNV	Uncertain Significance	453938	rs539161089	GRCh37: 1:45288751-45288751 GRCh38: 1:44823079-44823079
10	PTCH2	NM_003738.5(PTCH2):c.565C>G (p.Leu189Val)	SNV	Uncertain Significance	524558	rs747885797	GRCh37: 1:45297430-45297430 GRCh38: 1:44831758-44831758
11	PTCH2	NM_003738.5(PTCH2):c.109C>T (p.Arg37Cys)	SNV	Uncertain Significance	570977	rs768246990	GRCh37: 1:45307675-45307675 GRCh38: 1:44842003-44842003
12	PTCH2	NM_003738.5(PTCH2):c.19C>G (p.Leu7Val)	SNV	Uncertain Significance	453931	rs1030456781	GRCh37: 1:45308586-45308586 GRCh38: 1:44842914-44842914
13	PTCH1	NM_000264.5(PTCH1):c.68C>A (p.Ala23Asp)	SNV	Uncertain Significance	930926	rs761204245	GRCh37: 9:98270576-98270576 GRCh38: 9:95508294-95508294
14	PTCH2	NM_003738.5(PTCH2):c.3185T>G (p.Val1062Gly)	SNV	Uncertain Significance	931578	rs1652996959	GRCh37: 1:45288987-45288987 GRCh38: 1:44823315-44823315
15	PTCH2	NM_003738.5(PTCH2):c.2716G>C (p.Glu906Gln)	SNV	Uncertain Significance	952970	rs751579508	GRCh37: 1:45292420-45292420 GRCh38: 1:44826748-44826748
16	PTCH1	NM_000264.5(PTCH1):c.4051A>G (p.Asn1351Asp)	SNV	Uncertain Significance	188148	rs786204103	GRCh37: 9:98209487-98209487 GRCh38: 9:95447205-95447205
17	PTCH1	NM_000264.5(PTCH1):c.4049G>A (p.Arg1350Gln)	SNV	Uncertain Significance	577136	rs978722722	GRCh37: 9:98209489-98209489 GRCh38: 9:95447207-95447207
18	PTCH1	NM_000264.5(PTCH1):c.4043A>G (p.Asn1348Ser)	SNV	Uncertain Significance	220391	rs371943557	GRCh37: 9:98209495-98209495 GRCh38: 9:95447213-95447213
19	PTCH1	NM_000264.5(PTCH1):c.4024C>T (p.Arg1342Cys)	SNV	Uncertain Significance	409167	rs781539921	GRCh37: 9:98209514-98209514 GRCh38: 9:95447232-95447232
20	PTCH1	NM_000264.5(PTCH1):c.3919C>T (p.Pro1307Ser)	SNV	Uncertain Significance	132753	rs574880967	GRCh37: 9:98209619-98209619 GRCh38: 9:95447337-95447337
21	PTCH1	NM_000264.5(PTCH1):c.3908G>T (p.Arg1303Leu)	SNV	Uncertain Significance	524547	rs779365332	GRCh37: 9:98209630-98209630 GRCh38: 9:95447348-95447348
22	PTCH1	NM_000264.5(PTCH1):c.3734A>G (p.Gln1245Arg)	SNV	Uncertain Significance	409208	rs767792734	GRCh37: 9:98211421-98211421 GRCh38: 9:95449139-95449139
23	PTCH1	NM_000264.5(PTCH1):c.3575G>A (p.Arg1192His)	SNV	Uncertain Significance	486183	rs762040036	GRCh37: 9:98211580-98211580 GRCh38: 9:95449298-95449298
24	PTCH1	NM_000264.5(PTCH1):c.2671G>A (p.Gly891Ser)	SNV	Uncertain Significance	220717	rs570091335	GRCh37: 9:98224170-98224170 GRCh38: 9:95461888-95461888
25	PTCH1	NM_000264.5(PTCH1):c.2635G>A (p.Asp879Asn)	SNV	Uncertain Significance	216378	rs750373573	GRCh37: 9:98224206-98224206 GRCh38: 9:95461924-95461924
26	PTCH1, LOC100507346	NM_000264.5(PTCH1):c.2440A>C (p.Asn814His)	SNV	Uncertain Significance	188150	rs754623561	GRCh37: 9:98229518-98229518 GRCh38: 9:95467236-95467236
27	PTCH1, LOC100507346	NM_000264.5(PTCH1):c.2287G>T (p.Val763Phe)	SNV	Uncertain Significance	524507	rs544963328	GRCh37: 9:98229671-98229671 GRCh38: 9:95467389-95467389
28	PTCH1, LOC100507346	NM_000264.5(PTCH1):c.1989G>C (p.Gln663His)	SNV	Uncertain Significance	237462	rs753002023	GRCh37: 9:98231294-98231294 GRCh38: 9:95469012-95469012
29	PTCH1	NM_000264.5(PTCH1):c.1138G>A (p.Glu380Lys)	SNV	Uncertain Significance	409137	rs772903899	GRCh37: 9:98241359-98241359 GRCh38: 9:95479077-95479077
30	PTCH1	NM_000264.5(PTCH1):c.949C>T (p.Leu317Phe)	SNV	Uncertain Significance	578248	rs1380199153	GRCh37: 9:98242369-98242369 GRCh38: 9:95480087-95480087
31	PTCH1	NM_000264.5(PTCH1):c.901G>A (p.Asp301Asn)	SNV	Uncertain Significance	524544	rs767601899	GRCh37: 9:98242716-98242716 GRCh38: 9:95480434-95480434
32	PTCH1	NM_000264.5(PTCH1):c.412C>T (p.Arg138Cys)	SNV	Uncertain Significance	486174	rs139535966	GRCh37: 9:98248139-98248139 GRCh38: 9:95485857-95485857
33	PTCH1	NM_000264.5(PTCH1):c.181G>A (p.Ala61Thr)	SNV	Uncertain Significance	409215	rs150069331	GRCh37: 9:98270463-98270463 GRCh38: 9:95508181-95508181
34	PTCH1	NM_000264.5(PTCH1):c.37C>G (p.Arg13Gly)	SNV	Uncertain Significance	188208	rs779791579	GRCh37: 9:98270607-98270607 GRCh38: 9:95508325-95508325
35	PTCH1	NM_000264.5(PTCH1):c.4162G>A (p.Gly1388Arg)	SNV	Uncertain Significance	135105	rs587778631	GRCh37: 9:98209376-98209376 GRCh38: 9:95447094-95447094
36	PTCH1	NM_000264.5(PTCH1):c.4138G>A (p.Ala1380Thr)	SNV	Uncertain Significance	577111	rs111481152	GRCh37: 9:98209400-98209400 GRCh38: 9:95447118-95447118
37	PTCH1	NM_000264.5(PTCH1):c.37C>T (p.Arg13Cys)	SNV	Uncertain Significance	930369	rs779791579	GRCh37: 9:98270607-98270607 GRCh38: 9:95508325-95508325
38	PTCH1	NM_001083603.3(PTCH1):c.2T>C (p.Met1Thr)	SNV	Uncertain Significance	930744	rs1039069537	GRCh37: 9:98279101-98279101 GRCh38: 9:95516819-95516819

Sources

Expression for Basal Cell Carcinoma, Multiple

Search GEO for disease gene expression data for Basal Cell Carcinoma, Multiple.

Sources

Pathways for Basal Cell Carcinoma, Multiple

Sources

GO Terms for Basal Cell Carcinoma, Multiple

Biological processes related to Basal Cell Carcinoma, Multiple according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	response to organic cyclic compound	GO:0014070	8.62	PTCH1 CYP1A1

Sources

Sources for Basal Cell Carcinoma, Multiple

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: BSL011 MIFTS: 26	Basal Cell Carcinoma, Multiple Categories: Cancer diseases, Genetic diseases, Mental diseases, Rare diseases, Respiratory diseases, Skin diseases	Data Licensing For inquiries, contact: [email protected]
Genes Variations Tissues Related diseases Publications Drugs Expand all tables